April 24, 2025
| Today’s news and insights for medtech leaders
The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.
|
Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart rhythm disorder.
|
From the Archives
Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool for ventricular tachycardia as CEO of startup Field Medical.
|
Product liability coverage is an essential tool for safeguarding your business’s balance sheet and reputation. Learn how to choose a risk management partner for your life sciences business in
|
The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the impact of the tariffs.
|
The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of dollars from President Donald Trump’s tariff policies.
|
CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend timelines for robot purchases.
|
Commercial + Medical to Drive Speed & Patient Outcomes
|
|
From Our Library
Custom content for Salesforce
|
Playbook
Custom content for Hy-Tek Intralogistics
|
Playbook
Custom content for Salesforce & Cognizant
|
| 
